Expired Tender Germany ICB TOT Ref. 99113492

Project Sponsorship Funding Program for Gene Tender - 99113492

Tender notice from Germany, published on 21 Mar 2024.

Executive Summary

The BERLIN INSTITUTE FOR HEALTH RESEARCH AT THE CHARITE (BIH) has issued a Tender notice for the procurement of a Project Sponsorship Funding Program for Gene and Cell Therapies in the Germany. This Tender notice was published on 21 Mar 2024 and is scheduled to close on 18 Apr 2024, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 99113492, while the tender notice number is 166869-2024 and Register on the platform.

Key facts

Summary
Project Sponsorship Funding Program for Gene and Cell Therapies
TOT Ref. No.
99113492
Document Ref. No.
166869-2024
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
21 Mar 2024
Bid deadline
18 Apr 2024
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The Berlin Institute for Health Research in the Charite (BIH), Anna-Louisa-Karsch Str. 2, 10178 Berlin, intends to select the project sponsor for the "Target Product Definition and Clinical Trial Development" funding program as well as for defined individual elements of personal fundingto award gene and cell-based therapies as part of the development and implementation of the national strategy.
More information can be found in the documents provided on the Charite's awarding platform (https://vergabeplattform.charite.de).
Project sponsorship Foerderprogram gene and cell therapies
The Berlin Institute for Health Research at the Charite (BIH), Anna-Louisa-Karsch Str. 2, 10178 Berlin, intends to select the project sponsor for the "Target Product Definition and Clinical Trial Development" funding program as well as for defined individual elementselements of personal funding as part of the development and implementation of the national strategy to award gene and cell-based therapies.
More information can be found in the documents provided on the Charite's awarding platform (https://vergabeplattform.charite.de).
Doc Title: Project sponsorship funding program for gene and cell therapies
Contract Type: services
Document Type: Contract Notice

Reference Number: EL 2/24

Contract Type: services

Estimated Value: 0 - EUR

Authority Type: body-pl-ra

Doc Title: Projekttraegerschaft Foerderprogramm Gen- und Zelltherapien

Dispatch Date: 2024-03-18

Publish Date: 2024-03-20

Submission Date: 2024-04-18

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Project Sponsorship Funding Program for Gene and Cell Therapies was 18 Apr 2024. Bidding is closed.

This tender has been issued by BERLIN INSTITUTE FOR HEALTH RESEARCH AT THE CHARITE (BIH) in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 73210000 - Research consultancy services, 79421000 - Project-management services other than for construction work, 73200000 - Research and development consultancy services.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 99113492. The purchaser document reference is 166869-2024.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Research and Development, Other Services in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.